3 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
Follow Phantom Limb: new trials by email Literature Review of Phantom Limb trials Research Report on Phantom Limb
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Adezunap, Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Continuous Sciatic Nerve Block vs Epidural Analgesia in Lower Limb Amputation for Postoperative Pain Epidural catheter, Continuous sciatic nerve block - Phantom Limb Pain, Pain, Chronic | Phase 3 | Unknown | Universidad de Antioquia | 112 | 2022-12-01 | 2022-11-08 |
Chronic Pain (3) · Agnosia (2) · Brain Injuries, Traumatic (2) · Marijuana Abuse (2) · Multiple Sclerosis (2) · Neuralgia (2) · Pain (2) · Paraplegia (2) · Somatoform Disorders (2) · Stroke (2)
Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pain, Postoperative (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Perceptual Disorders (3) · Postoperative Complications (3) · Signs and Symptoms (3) · Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Brain Diseases (2) · Brain Injuries (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2)
Apurano Pharmaceuticals GmbH (2) · Universidad de Antioquia (1)
Germany (2) · Colombia (1)